Surveys

This survey asks YOUR opinion about best practices that you think should govern pharma's collaboration with online

This survey solicits your opinion on the appropriateness of using behavioral targeting techniques in online pharma marketing.

This surevy solicits your opinion on the benefits of pharma access to prescribing information, physicians ability to opt-out, and appropriate uses of Rx data by pharmaceutical companies.

This survey solicited opinions on regulatory issues regarding Rx drug and device promotion via the Internet in general and social media in particular.

This survey solicits your opinion possible FDA future decisions regarding off-label drug promotion to patient and consumer audiences.

This survey is designed to inform the discussion on the pros and cons of how Social, Mobile, & Gaming Technologies technologies drive patient engagement and what value they have in solving the long-standing medication adherence problem.

This survey asks YOUR opinion about the privacy issues raised in a brief filed with the FTC regarding the online marketing practices of pharmaceutical and other health-related companies.

As more and more pharmaceutical companies launch social networking platforms associated with their brands, some will allow users (consumers, patients, and physicians) to post comments as part of ongoing discussions about drugs and/or the conditions they treat. Recent pharma experience with social media discussions demonstrate how important it is to properly manage online communities. Perhaps the most important management tool is moderation.

This surevy solicits your opinion on specific marketing tactics involving CGC and buzz, specifically from a pharmaceutical marketing point of view.

This survey asks your opinion regarding several issues faced by pharma companies when developing mobile applications (apps) for physicians and consumers. Issues include impact of regulation by FDA, privacy, trust, accuracy, and 3rd-party certification as well as industry self-regulatory guidelines.